“We're going to make sure we reduce the premiums and reduce drug prices by making sure that there's competition that doesn't exist now by allowing Medicare to negotiate drug prices with the insurance companies.”
Sources (click to view full provenance)
Propose an edit to this promise's details
Suggest a sourced correction to the promise text, topic, scope, significance, or dates. Changing the promise text requires a source. Your suggestion is reviewed before it changes the record.
Free — it takes a minute. New here? Create an account and complete the Contributor Agreement once.
Assessments
evidence-backed verdictsThese are sourced verdicts from fact-checkers or community evidence reviews — not opinions.
The promise's explicit, verifiable mechanism -- allowing Medicare to negotiate drug prices -- was fully delivered. Biden championed and signed the Inflation Reduction Act (P.L. 117-169) on August 16, 2022, which for the first time granted Medicare authority to directly negotiate prescription drug prices. This moved from promise to enacted law to concrete outcome: CMS negotiated prices for the first 10 Part D drugs (Eliquis, Jardiance, Januvia, etc.), those prices took effect January 1, 2026, and they represent 38 to 79 percent discounts off 2023 list prices, with an estimated $1.5 billion in beneficiary savings. Independent verification (CMS fact sheet, KFF, and corroborating search results) confirms every cited fact. FULL is party-neutral: a president of either party who promised Medicare negotiation and signed a law now producing live negotiated prices would earn FULL; CHAMPIONED would understate an effort that fully landed. Confidence shaved slightly from the prior 0.95 because the secondary 'reduce premiums' element is a more mixed record (the IRA capped Part D premium growth but actual premiums required a stabilization demonstration) and negotiation currently covers only a subset of drugs -- neither undermines the core mechanism, which was 100 percent enacted and is in effect.
Your opinion on this assessment(clearly labeled opinion)
Sign in to vote.
Discussion
community opinionsComments are user opinions — not verdicts. They do not affect the official assessment.
Sign in to join the discussion.
Propose a correction
community accountabilitySee an error in the promise text, status, significance, or missing source? Submit a sourced correction — a reviewer will evaluate and apply it if accurate. Your submission must cite evidence; unsourced changes are not accepted.
Sign in or create an account to propose a correction.
Debate
sourced community argumentsThese are sourced community arguments — not StumpWatch assessments. Each cites a source and is community-contributed; it does not change the official status or rating above.
No arguments yet
Be the first to weigh in. Every argument cites a source and is reviewed before it publishes. Create an account to add one and help keep this promise honest.
Add a sourced argument
Cite a source for your point. Submissions are held for reviewer approval before they appear.
Sign in or create an account to add an argument.